Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms
Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms
A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer
COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic
Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic?
Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19
Managing toxicities associated with immune-checkpoint inhibitors
I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer
COVID-19: Managing paediatric patients under the COVID pandemic
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma
An oncologist's experience of managing breast cancer during the COVID-19 outbreak
COVID-19: The situation in Florida and managing lung cancer patients
New oncogenic drivers in NSCLC